Broncho-munal P, capsules 3.5mg 10 pcs

ATX code: L03AX.

Pharmacotherapeutic group:immunostimulant.
Nosological classification: ICD-10

Pharmacological properties

Pharmacodynamics
The drug Broncho-Munal® P has an immune stimulating effect, increasing immunity against respiratory tract infections.
In patients receiving the drug Broncho-Munal ® P, the protective properties of the body against bacteria and viruses are enhanced.
After taking the capsule bacterial lysate accumulates in the peer plaques of the mucous membrane of the gastrointestinal tract, particularly located in the small intestine. The antigen-presenting cells in the peyer plaques are activated by the bacterial lysate and subsequently stimulate other cell types (B-lymphocytes) responsible for specific immunity. This leads to an increase in the number of circulating B-lymphocytes leading to increased production of polyclonal antibodies, especially serum IgG and IgA, secreted by the respiratory mucosa and salivary glands.

The drug also affects non-specific immunity by stimulating leukocytes, characterized by increase of myeloid and lymphoid cells number and selective increase of receptors expression on their surface.

Clinically Broncho-Munal® P reduces the frequency of acute respiratory tract infections, reduces the duration of their course, reduces the likelihood of exacerbations of chronic bronchitis, as well as increases the body’s resistance to infections of the respiratory system. It also reduces the need to use other medicines, especially antibiotics.

Indications

Active ingredient

Composition

How to take, the dosage

Children from 6 months to 12 years. The drug is taken 1 capsule daily in the morning, on an empty stomach, 30 minutes before a meal. For children under 3 years of age, or if the child is difficult to swallow the capsule, it should be opened, the contents mixed with a small amount of liquid (tea, milk or juice).

– For prevention of recurrent respiratory tract infections and exacerbations of chronic bronchitis the drug is used in three courses of 10 days each, the interval between courses is 20 days.

In combination therapy of acute respiratory tract infections the drug is used until relief of symptoms, but not less than 10 days. In case of antibiotic therapy Broncho-Munal® P should be taken in combination with antibiotics from the beginning of treatment.

The next 2 months the preparation can be used prophylactically: by courses of 10 days, the interval between the courses is 20 days.

Interaction

Special Instructions

Synopsis

Contraindications

Side effects

Overdose

Similarities